Our programme has two aims:
- To understand the core processes involved in the onset, maintenance, and recovery from mood and anxiety disorders such as depression and posttraumatic stress disorder (PTSD) in children, adolescents, and adults.
- To translate this understanding to generate novel forms of psychological treatment for these syndromes and to provide greater clarity concerning the mechanisms of action of existing treatments.
Our research is guided by the MRC’s framework for developing complex interventions and occupies a trajectory ranging from basic cognitive neuroscience through to randomised clinical trials. This work is grounded within a transdiagnostic framework, taking the view that the greatest potential for understanding and treating affective disorders is to focus on maladaptive underlying psychological and biological processes that cross traditional diagnostic boundaries, rather than pursue diagnosis-led research.
We use cognitive-experimental, psychophysiology, genetic, and neuroimaging methodologies in the laboratory and prospective longitudinal and clinical trial designs outside the laboratory. Our basic and pre-clinical science is carried out at the CBU. Our clinical research is carried out at the Cambridge Centre for Affective Disorders (C2:AD) directed by Tim Dalgleish.
Tim Dalgleish, Clinical Psychologist & Programme Leader
Susanne Schweizer, Investigator Scientist
Jason Stretton, Investigator Scientist
Darren Dunning, Post-Doctoral Scientist
Melissa Black, Clinical Psychologist
Anna Bevan, Clinical Psychologist and PhD Student
Ben Goodall, Clinical Psychologist and PhD Student
Daisy Follett, PhD Student
Georgina Clifford, PhD Student
Kirsty Griffiths, PhD Student
Jenna Parker, Research Assistant
Alicia Smith, Student Intern